The present invention provides Chordin-Like (CHL) polypeptides and nucleic
acid molecules encoding the same. The invention also provides selective
binding agents, vectors, host cells, and methods for producing CHL
polypeptides. The invention further provides pharmaceutical compositions
and methods for the diagnosis, treatment, amelioration, and/or prevention
of diseases, disorders, and conditions associated with CHL polypeptides.